Transplantation of thymus tissue in complete DiGeorge syndrome

New England Journal of Medicine

Volumn 341, Issue 16, 1999, Pages 1180-1189

  Markert, M Louise ^a,b   Boeck, Andreas ^c   Hale, Laura P ^a,b   Kloster, Amy L ^a   McLaughlin, Tanya M ^a   Batchvarova, Milena N ^a   Douek, Daniel C ^d   Koup, Richard A ^d   Kostyu, Donna D ^a,c   Ward, Frances E ^a,c   Rice, Henry E ^a   Mahaffey, Samuel M ^a   Schiff, Sherrie E ^d   Buckley, Rebecca H ^b   Haynes, Barton F ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGEORGE SYNDROME; FEMALE; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMUS GRAFT;

ABNORMALITIES, MULTIPLE; BIOPSY; CELL DIVISION; DIGEORGE SYNDROME; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MITOGENS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0033554731     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199910143411603     Document Type: Article

References (48)

1. Thomas RA, Landing BH, Wells TR. Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl 1987;3:43-66.
2. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr 1979;94:883-90.
3. DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. In: Bergsma D, ed. Birth defects original article series. Vol. 4. White Plains, N.Y.: National Foundation March of Dimes, 1968:116.
4. de la Chapelle A, Herva R, Koivisto M, Aula P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 1981;57:253-6.
5. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993;30:813-7.
6. Daw SC, Taylor C, Kraman M, et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet 1996;13:458-60.
7. Yamagishi H, Garg V, Matsuoka R, Thomas T, Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 1999;283:1158-61.
8. Hong R. The DiGeorge anomaly: CATCH 22, DiGeorge/velocardiofacial syndrome. Semin Hematol 1998;35:282-90.
9. Muller W, Peter HH, Wilken M, et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988;147:496-502.
10. Muller W, Peter HH, Kallfelz HC, Franz A, Rieger CH. The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989;149:96-103.
11. Bastian J, Law S, Vogler L, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989;115:391-6.
12. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998;132:15-21.
13. Goldsobel AB, Haas A, Stiehm ER. Bone marrow transplantation in DiGeorge syndrome. J Pediatr 1987;111:40-4.
14. Borzy MS, Ridgway D, Noya FJ, Shearer WT. Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol 1989;9:386-92.
15. Bowers DC, Lederman HM, Sicherer SH, Winkelstein JA, Chen AR. Immune reconstitution of complete DiGeorge anomaly by transplantation of unmobilized blood mononuclear cells. Lancet 1998;352:1983-4.
16. August CS, Berkel AI, Levey RH, Rosen FS, Kay HE. Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet 1970;1:1080-3.
17. Cleveland WW, Fogel BJ, Brown WT, Kay HE. Foetal thymic transplant in a case of DiGeorge's syndrome. Lancet 1968;2:1211-4.
18. Jose DG, Barnes G, Rossiter EJ, Myers NA, Fitzgerald MG. Reconstitution of cellular immune function in a child with thymic aplasia by foetal thymus grafting. Aust N Z J Med 1974;4:267-73.
19. Mayumi M, Kimata H, Suchiro Y, et al. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr 1989;148:518-22.
20. Reece ER, Gartner JG, Seemayer TA, Joncas JH, Pagano JS. EpsteinBarr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res 1981;41:4243-7.
21. Dictor M, Fasth A, Oiling S. Abnormal B-cell proliferation associated with combined immunodeficiency, cytomegalovirus, and cultured thymus grafts. Am J Clin Pathol 1984;82:487-90.
22. Borzy MS, Hong R, Horowitz SD, et al. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med 1979;301:565-8.
23. Markert ML, Kostyu DD, Ward FE, et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol 1997;158:998-1005.
24. Hong R, Moore AL. Organ culture for thymus transplantation. Transplantation 1996;61:444-8.
25. Markert ML, Watson TJ, Kaplan I, Hale LP, Haynes BF. The human thymic microenvironment during organ culture. Clin Immunol Immunopathol 1997;82:26-36.
26. Buckley RH, Schiff SE, Sampson HA, et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
27. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
28. Kostyu DD, Pfohl J, Ward FE, Lee J, Murray A, Amos DB. Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays. Hum Immunol 1993;38:148-58.
29. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-5.
30. Davis CM, McLaughlin TM, Watson TJ, et al. Normalization of the peripheral blood T cell receptor Vβ repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome. J Clin Immunol 1997; 17:167-75.
31. Wells TR, Gilsanz V, Senac MO Jr, Landing BH, Vachon L, Takahashi M. Ossification centre of the hyoid bone in DiGeorge syndrome and tetralogy of Fallot. Br J Radiol 1986;59:1065-8.
32. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-22.
33. Markert ML, Majure M, Harville TO, Hulka G, Oldham KO. Severe laryngomalacia and bronchomalacia in DiGeorge syndrome and CHARGE association. Pediatr Pulmonol 1997;24:364-9.
34. Davenport SL, Hefner MA, Mitchell JA. The spectrum of clinical features in CHARGE syndrome. Clin Genet 1986;29:298-310.
35. Pagon RA, Graham JM Jr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr 1981;99:223-7.
36. Metlay LA, Smythe PS, Miller ME. Familial CHARGE syndrome: clinical report with autopsy findings. Am J Med Genet 1987;26:577-81.
37. Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol 1986;40: 136-41.
38. Jenkinson EJ, Franchi LL, Kingston R, Owen JJ. Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments. Eur J Immunol 1982;12:583-7.
39. Kong FK, Chen CLH, Six A, Hockett RD, Cooper MD. T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A 1999;96:1536-40.
40. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986;68:770-3.
41. Zinkernagel RM, Althage A, Waterfield E, et al. Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med 1980;151:376-99.
42. Lake JP, Andrew ME, Pierce CW, Braciale TJ. Sendai virus-specific, H2-restricted cytotoxic T lymphocyte responses of nude mice grafted with allogenic or semi-allogenic thymus glands. J Exp Med 1980;152:1805-10.
43. Kruisbeek AM, Sharrow SO, Mathicson BJ, Singer A. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J Immunol 1981;127:2168-76.
44. Kast WM, de Waal LP, Melief CJ. Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells. J Exp Med 1984;160:1752-66.
45. Longo DL, Kruisbeek AM, Davis ML, Matis LA. Bone marrow-derived thymic antigen-presenting cells determine self-recognition of Ia-restricted T lymphocytes. Proc Natl Acad Sci U S A 1985;82:5900-4.
46. Benoist C, Mathis D. Positive selection of the T cell repertoire: where and when does it occur? Cell 1989;58:1027-33.
47. Hong R, Schulte-Wissermann H, Jarrett-Toth E, Horowitz SD, Manning DD. Transplantation of cultured thymic fragments. II. Results in nude mice. J Exp Med 1979;149:398-415.
48. Zhao Y, Fishman JA, Sergio JJ, et al. Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized mice. J Immunol 1997; 158:1641-9.